Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study

The roles of sex hormones such as estradiol, testosterone, and sex hormone-binding globulin (SHBG) in the etiology of lung and colorectal cancers in women, among the most common cancers after breast cancer, are unclear. This Mendelian randomization (MR) study evaluated such potential causal associations in women of European ancestry. We used summary statistics data from genome-wide association studies on sex hormones and from the Trøndelag Health Study (HUNT) and large consortia on cancers. There was suggestive evidence of 1-standard deviation increase in total testosterone levels being associated with a lower risk of lung non-adenocarcinoma (hazard ratio 0.60, 95% confidence interval 0.37-0.98) in the HUNT Study. However, this was not confirmed by using data from a larger consortium. In general, we did not find convincing evidence to support a causal role of sex hormones on risk of lung and colorectal cancers in women of European ancestry.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2024-10-12
DOI
https://doi.org/10.1038/s41598-024-75305-4
Citations
3
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
1.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study

Jewel Samadder, Yi‐Qian Sun, Demetrius Albanes, Xiao‐Mei Mai et al.
3 citations
Scientific Reports
Genetic Associations and Epidemiology
1.65
article

Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study

Jewel Samadder, Yi‐Qian Sun, Demetrius Albanes, Xiao‐Mei Mai, Sébastien Küry, Christopher I. Li, Marion Denos, Emily White, Andrea N. Burnett‐Hartman, Ben Michael Brumpton, Mark A. Jenkins, Yafang Li, Peter T. Campbell
article en
3 citations

Abstract

The roles of sex hormones such as estradiol, testosterone, and sex hormone-binding globulin (SHBG) in the etiology of lung and colorectal cancers in women, among the most common cancers after breast cancer, are unclear. This Mendelian randomization (MR) study evaluated such potential causal associations in women of European ancestry. We used summary statistics data from genome-wide association studies on sex hormones and from the Trøndelag Health Study (HUNT) and large consortia on cancers. There was suggestive evidence of 1-standard deviation increase in total testosterone levels being associated with a lower risk of lung non-adenocarcinoma (hazard ratio 0.60, 95% confidence interval 0.37-0.98) in the HUNT Study. However, this was not confirmed by using data from a larger consortium. In general, we did not find convincing evidence to support a causal role of sex hormones on risk of lung and colorectal cancers in women of European ancestry.

Scientific ReportsVol. 14(1)
National Institutes of Health (US), Albert Einstein College of Medicine (US), Kaiser Permanente (US), The University of Melbourne (AU), Baylor College of Medicine (US), Norwegian University of Science and Technology (NO), Fred Hutch Cancer Center (US), St Olav's University Hospital (NO), Houston Institute for Clinical Research (US), Mayo Clinic in Arizona (US), National Cancer Institute (US), Génétique Médicale & Génomique Fonctionelle (FR), Nantes Université (FR)
U.S. Department of Health and Human Services, American Cancer Society, Damon Runyon Cancer Research Foundation, World Health Organization, Brigham and Women's Hospital, Florida Department of Health, Memorial Sloan-Kettering Cancer Center, Univerzita Karlova v Praze, Johns Hopkins University, University of Pittsburgh, Harvard T.H. Chan School of Public Health, Deutsches Krebsforschungszentrum, University of South Florida, Norges Teknisk-Naturvitenskapelige Universitet, Moffitt Cancer Center, Marshfield Clinic Research Foundation, Mike and Josie Harper Cancer Research Institute, Centres de Recerca de Catalunya, Cancer Research UK, National Institute for Health and Care Research, Imperial College London, Institut National de la Santé et de la Recherche Médicale, Grantová Agentura České Republiky, Bundesministerium für Bildung und Forschung, Chonnam National University, Fundación Científica Asociación Española Contra el Cáncer, Cancerfonden, Generalitat de Catalunya, Ministerstvo Zdravotnictví Ceské Republiky, Ministerio de Economía y Competitividad, Ligue Contre le Cancer, Vetenskapsrådet, Helse Midt-Norge, Umeå Universitet, Associazione Italiana per la Ricerca sul Cancro, Deutsche Krebshilfe, Institut Gustave-Roussy, Mutuelle Générale de l'Education Nationale, Karl-Franzens-Universität Graz, Medizinische Universität Graz, Xunta de Galicia, Biobanco Vasco, Chonnam National University Hwasun Hospital, National Institutes of Health, Centers for Disease Control and Prevention, Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet, Canadian Institutes of Health Research, Medical Research Council, World Cancer Research Fund, National Health and Medical Research Council, Cancer Council Victoria, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, Wageningen University and Research, NIHR Imperial Biomedical Research Centre, School of Public Health, Imperial College London, Faculty of Medicine and Health, University of Sydney, Norwegian Institute of Public Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 14%
Genetic Associations and Epidemiology
1.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.